Cargando…
Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005498/ https://www.ncbi.nlm.nih.gov/pubmed/35414003 http://dx.doi.org/10.1038/s41598-022-10374-x |
_version_ | 1784686474379132928 |
---|---|
author | Tanaka, Yuki Wada, Hiroshi Goto, Risa Osada, Toshihiro Yamamura, Keisuke Fukaya, Satoshi Shimizu, Atsushi Okubo, Mitsuru Minamiguchi, Kazuhisa Ikizawa, Koichi Sasaki, Eiji Utsugi, Teruhiro |
author_facet | Tanaka, Yuki Wada, Hiroshi Goto, Risa Osada, Toshihiro Yamamura, Keisuke Fukaya, Satoshi Shimizu, Atsushi Okubo, Mitsuru Minamiguchi, Kazuhisa Ikizawa, Koichi Sasaki, Eiji Utsugi, Teruhiro |
author_sort | Tanaka, Yuki |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9005498 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90054982022-04-13 Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice Tanaka, Yuki Wada, Hiroshi Goto, Risa Osada, Toshihiro Yamamura, Keisuke Fukaya, Satoshi Shimizu, Atsushi Okubo, Mitsuru Minamiguchi, Kazuhisa Ikizawa, Koichi Sasaki, Eiji Utsugi, Teruhiro Sci Rep Author Correction Nature Publishing Group UK 2022-04-12 /pmc/articles/PMC9005498/ /pubmed/35414003 http://dx.doi.org/10.1038/s41598-022-10374-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Author Correction Tanaka, Yuki Wada, Hiroshi Goto, Risa Osada, Toshihiro Yamamura, Keisuke Fukaya, Satoshi Shimizu, Atsushi Okubo, Mitsuru Minamiguchi, Kazuhisa Ikizawa, Koichi Sasaki, Eiji Utsugi, Teruhiro Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice |
title | Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice |
title_full | Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice |
title_fullStr | Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice |
title_full_unstemmed | Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice |
title_short | Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice |
title_sort | author correction: tas0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with pd-1/pd-l1 blockade in hla-a*2402 mice |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005498/ https://www.ncbi.nlm.nih.gov/pubmed/35414003 http://dx.doi.org/10.1038/s41598-022-10374-x |
work_keys_str_mv | AT tanakayuki authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT wadahiroshi authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT gotorisa authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT osadatoshihiro authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT yamamurakeisuke authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT fukayasatoshi authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT shimizuatsushi authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT okubomitsuru authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT minamiguchikazuhisa authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT ikizawakoichi authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT sasakieiji authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice AT utsugiteruhiro authorcorrectiontas0314anovelmultiepitopelongpeptidevaccineshowedsynergisticantitumorimmunitywithpd1pdl1blockadeinhlaa2402mice |